| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |